<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02853019</url>
  </required_header>
  <id_info>
    <org_study_id>6152</org_study_id>
    <nct_id>NCT02853019</nct_id>
  </id_info>
  <brief_title>Emotion and Motivation in Patients With Psychosis</brief_title>
  <official_title>Influence of Emotion and Motivation on Behaviour and Neural Activity in Patients With Psychosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anhedonia and avolition reflect emotional and motivational disorders, respectively. However,
      if these disorders play a major role in the symptomatology of schizophrenia, their mechanisms
      remain poorly understood, and existing treatments are inefficient on these symptoms. The
      literature suggests that the impairment does not concern emotion or motivation per se, but
      rather their influence on cognition. This project aims at using recent advances in the
      fundamental domain to better understand the cognitive and neuronal mechanisms of the
      patients' alterations, and especially how emotion and motivation influence cognition in
      schizophrenia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the amplitude of the CNV (Contingent Negative Variation) as a function of the primer displayed on the screen</measure>
    <time_frame>During EEG sessions, at experimental session 1 (Day 0) and experimental session 2 (up to Day 120)</time_frame>
    <description>Before each cognitive trial a primer will be displayed, which will be either neutral or convey emotion or motivation. The investigators will check whether this primer affects the subjects preparation by measuring the CNV, which is an evoked potential recorded with electroencephalography, and indexing preparatory effort.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the amplitude of the LPP (Late Positive Potential) as a function of the primer displayed on the screen</measure>
    <time_frame>During EEG sessions, at experimental session 1 (Day 0) and experimental session 2 (up to Day 120)</time_frame>
    <description>The investigators will check whether primers affect the subjects attention by measuring the LPP, which is an evoked potential recorded with electroencephalography, and indexing sustained attention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with schizophrenia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electroencephalogram</intervention_name>
    <description>electrophysiological measurements (evoked potentials) based on neural activity when visualizing stimuli</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive tasks</intervention_name>
    <description>- clinical scales and subjective assessments of emotional and motivational stimuli</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>subjective evaluation scales</intervention_name>
    <description>- clinical scales and subjective assessments of emotional and motivational stimuli</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnostic and Statistical Manual of Mental Disorders criteria for schizophrenia

        Exclusion Criteria:

          -  addiction problem

          -  invalidating visual sensory problems

          -  neurological history

          -  for the healthy volunteers: psychiatric history
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne GIERSCH</last_name>
    <phone>03 88 11 64 71</phone>
    <email>giersch@unistra.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Unité INSERM 1114</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne GIERSCH, MD, PhD</last_name>
      <phone>03 88 11 64 71</phone>
      <email>giersch@unistra.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre VIDAILHET, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne GIERSCH, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabrice BERNA, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence LALANNE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sébastien WEIBEL, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 23, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Emotion</keyword>
  <keyword>motivation</keyword>
  <keyword>cognition</keyword>
  <keyword>schizophrenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

